Advertisement

Topics

Lee Biosolutions, Inc Company Profile

19:21 EST 23rd November 2017 | BioPortfolio


News Articles [48 Associated News Articles listed on BioPortfolio]

Will accelerated Laser PCR benefit time critical molecular tests?

Revolutionising the fundamentals of scientific and medical research. GNA Biosolutions is a Munich-based High-tech engineering firm which has developed instruments, OEM modules, and assays for ultra-fa...

Award Winning Customer Care from DSM BioSolutions

In this episode of PharmaTelevision News Review, filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton talks to Villaume Kal of DSM BioSolutions

Emergent BioSolutions embarks on another spending spree

Shares of US biotech firm Emergent BioSolutions closed up 3.3% at $36.04 yesterday, after it announced…

GNA Biosolutions Reveals New Ultrafast PCR Platform at Medical Trade Show

GNA Biosolutions GmbH, a molecular technology company, will showcase its new Pharos V8, the world's first laser PCR platform, at...

$175.41 Million in Sales Expected for Emergent Biosolutions, Inc. (EBS) This Quarter

Equities analysts predict that Emergent Biosolutions, Inc. will announce sales of $175.41 million for the current quarter, Zacks reports. Two analysts have provided estimates for Emergent Biosolutions...

Emergent Biosolutions (EBS) versus Theravance Biopharma (TBPHV) Head to Head Contrast

Theravance Biopharma and Emergent Biosolutions are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownershi...

Emergent BioSolutions strengthens manufacturing infrastructure with FDA-licensure

The US Food and Drug Administration (FDA) has approved Emergent BioSolutionsâ supplemental Biologics License Application (sBLA) for the manufacture of ACAM2000, the only FDA-licensed smallpox vaccine...

The Promise of P.L.E.A.S.E.®- Explanation by Christof Boehler, CEO of Pantec Biosolutions

In this episode of PharmaTelevision News Review, Fintan Walton talks to Christof Boehler, CEO of Pantec Biosolutions AG.

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [11 Associated Companies listed on BioPortfolio]

Pantec Biosolutions AG

Pantec Biosolutions specializes in precise skin microporation technology. Our proprietary P.L.E.A.S.E.® (Precise Laser EpidermAl SystEm) technology has been developed for:

Ocimum Biosolutions Ltd.

Ocimum Biosolutions is a life sciences R&D enabling company with three focus areas, BioIT, Microarrays and Research services. The Microarray division of Ocimum has been recently acquired from MWG Biot...

Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the bodyâ€...

DSM BioSolutions

Lee Biosolutions, Inc

More Information about "Lee Biosolutions, Inc" on BioPortfolio

We have published hundreds of Lee Biosolutions, Inc news stories on BioPortfolio along with dozens of Lee Biosolutions, Inc Clinical Trials and PubMed Articles about Lee Biosolutions, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lee Biosolutions, Inc Companies in our database. You can also find out about relevant Lee Biosolutions, Inc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record